查詢結果分析
來源資料
頁籤選單縮合
題 名 | 困難梭狀芽孢桿菌之藥物治療簡介=The Introduction of Medicine Treatment for Clostridium Difficile |
---|---|
作 者 | 廖珮斐; 詹千慧; | 書刊名 | 藥學雜誌 |
卷 期 | 35:4=141 2019.12[民108.12] |
頁 次 | 頁2-8 |
分類號 | 415.27 |
關鍵詞 | 困難梭狀桿菌; 抗生素相關腹瀉; Vancomycin; Fidaxomicin; Clostridium difficile; Antibiotics-associated diarrhea; |
語 文 | 中文(Chinese) |
中文摘要 | 困難梭狀桿菌感染是使用抗生素後引起腹瀉的原因之一,症狀從輕度腹瀉到偽膜 性腸炎,甚至死亡,治療困難梭狀桿菌感染,首先須盡快停用不必要之抗生素使用, 並給予適當之抗生素治療,如:vancomycin、metronidazole、fidaxomicin 等。目前證 據顯示,fidaxomicin 的治療成效優於 vancomycin,但仍有病人無法獲得緩解,甚至 是發生復發,藉由本文提供相關治療的進一步認識,以供臨床參考選擇。 |
英文摘要 | Clostridium difficile is the cause of diarrhea after using antibiotics. Symptoms range from mild diarrhea to pseudomembranous colitis and even death. Treatment of Clostridium infection is discontinuation of the inciting antibiotic agents and use of unnecessary antibiotics, likes vancomycin, metronidazole, fidaxomicin. Although current evidence shows that the fidaxomicin was superior to vancomycin, some patients cannot get relief, even recurrence. The purpose of this article is to provide further knowledge of relevant treatments for clinical selection. |
本系統中英文摘要資訊取自各篇刊載內容。